One avocado a day helps lower low-density lipoprotein
the ONA take:
Eating at least one avocado a day as part of a moderate-fat diet could help to lower “bad” cholesterol among the overweight and obese, according to a recent study published in the Journal of the American Heart Association.
Researchers led by Penny M. Kris-Etherton, PhD, at the Pennsylvania State University examined 45 subjects who were 21 to 70 years of age and were either overweight or obese. They wanted to see how avocado consumption affected risk factors for cardiovascular disease by replacing saturated fatty acids, also known as “bad” fats.
Subjects were required to follow three cholesterol-lowering diets during the 5-week duration of the study: lower-fat diet without avocado, moderate-fat diet without avocado, or a moderate-fat diet with one Hass avocado per day.
The researchers found that those who followed a moderate-fat diet with one avocado per day had low-density lipoprotein (LDL) levels that were 13.5 mg/dL lower than the baseline average, compared to the lower-fat diets without an avocado which were 8.3 mg/DL lower, and moderate-fat diets without an avocado which were 7.4 mg/dL lower.
In addition, additional blood measurements such as total cholesterol, small dense LDL, triglycerides and non-HDL, were found to be better in the moderate-fat with avocado group compared with the other two groups.
However, the researchers warn that their findings are based on a “proof-of-concept investigation” without any “real-world” application as of yet.
Eating at least one avocado a day as part of a moderate-fat diet could help to lower “bad” cholesterol among the overweight and obese
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|